Approval · Notice of Compliance 3020 · 1998
QUADRAMET: Notice of Compliance 3020
Issued June 22, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3020
- Date
- June 22, 1998
- Company
- Cytogen Corporation
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QUADRAMET | Not yet assigned | — |
Medicinal ingredients
- LEXIDRONAM 50 MCCI per ML